A leading pharmaceutical consulting and market research firm struggled with fragmented financial processes. They lacked a consolidated platform for costs and revenues, and their operations suffered from poor accounting practices, inconsistent client responses, and delayed communications. The absence of advisory support for accounting and pricing analysis further exacerbated their challenges.